slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 233,611-233,640
Pages 10,126
Rows per page 30
Component
233,611-233,640 of 303,780
21
The slide uses a combination of bulleted strategic initiatives and regional performance metrics (sourcing volumes vs. sales).Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations 1 hit
23
Hugo Boss | Results Presentation Deck | 44 slidesHugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations 1 hit
24
The slide uses a high-fashion aesthetic with a model overlay and large '2023' watermark.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
25
The slide uses brand imagery and color-coded blocks to present financial growth metrics.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
26
The slide uses a map-based visual layout to categorize performance by region.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
27
The slide uses a three-column layout to compare performance metrics across different sales channels.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
28
The chart shows a net decline of 30 basis points.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
30
The chart uses a dual-axis approach: bars for absolute EUR million values and a line for percentage of sales.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
31
The slide uses a three-column layout to present key financial performance indicators and their drivers.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
32
The slide highlights a 35% increase in dividend per share and shows the payout ratio remains within the 30-50% target range.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
33
Hugo Boss | Results Presentation Deck | 44 slidesHugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · Action1 hit
34
The slide uses a simple bar chart comparison between 2023 actuals and 2024 estimates.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · Action1 hit
36
Hugo Boss | Results Presentation Deck | 44 slidesHugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · Action1 hit
37
The slide uses a simple bar chart visualization to compare 2023 actuals with 2024 estimates.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · Action1 hit
43
Hugo Boss | Results Presentation Deck | 44 slidesHugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · Action1 hit
44
Hugo Boss | Results Presentation Deck | 44 slidesHugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · Action1 hit
01
Immix Biopharma | Investor Presentation Deck | 56 slidesImmix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
02
Immix Biopharma | Investor Presentation Deck | 56 slidesImmix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
04
The slide uses a grid-based layout to categorize team members into three distinct organizational tiers.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
05
The slide uses a Gantt-style chart to represent clinical trial stages.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
06
The slide uses a visual arrow graphic to imply forward momentum.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
08
The slide uses a comparison framework to contrast standard industry benchmarks with the company's clinical data.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
10
Includes a biological pathway diagram showing B-cell maturation and a pyramid diagram showing the hierarchy of disease targeting.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide highlights NXC-201's 100% overall response rate and superior cardiac response compared to CAEL-101 and Birtamimab.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
17
The slide uses a visual comparison between existing standard-of-care treatments (left) and the NXC-201 opportunity (center/right).Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
18
N-GENIUS TECHNOLOGY PLATFORM; NEXICART-1 Clinical Trial Data.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
20
Includes citations from Nature Medicine and Signal Transduction and Targeted Therapy to validate the scientific approach.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
21
Uses a combination of bar charts for preclinical data and a comparison table for clinical outcomes to demonstrate the superiority of the CD8 hinge optimization.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
22
The slide uses a schematic to compare HSL and LSH configurations, showing superior performance for HSL in expansion and cytotoxicity metrics.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
24
Immix Biopharma | Investor Presentation Deck | 56 slidesImmix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit